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Abstract Adipose derived multipotent stromal cells (ASCs)
isolated from brown versus white adipose tissues, may have
distinct in vitro properties, including response to cryopreserva-
tion, due to differences in tissue physiology. This study was
designed to determine the ultrastructure, immunophenotype,
in vitro expansion capabilities and multipotentiality of paired
canine ASCs harvested from subcutaneous (SUB) and
infrapatellar (IFP) adipose tissue up to cell passage (P) 3 before
and after cryopreservation. Adipocyte and ASC ultrastructure
from the same tissue were distinct, and morphologies of both
differed between tissue sources and with cryopreservation. Cell
expansion and colony forming unit frequencies were similar
between ASCs from both tissue sources before and after cryo-
preservation. Most fresh cells were CD29+, CD44+, CD90+
and CD34− up to P3. Cryopreserved P1 and P3 cells had lower
percentages of CD29+ and 44+ cells, respectively, compared to
fresh. Peroxisome proliferator-activated receptor γ (PPAR-γ)
gene expression and sex determining region Y-box 2 (SOX2),
CD29 and CD44 protein expression was lower in cryopre-
served versus fresh P3 ASCs. Both PPAR-γ and osteopontin
(OPN) protein expression increased in fresh and cryopreserved
P3 ASCs cultured in adipogenic and osteogenic induction me-
dium, respectively, while SOX2 decreased. Based on the study
findings, in vitro expansion and multipotentiality are not dis-
tinct among canine SUB and IFP ASCs before or after cryo-
preservation. However, cryopreservation alters ASC ultrastruc-
ture, immunophenotype and transcription factor expression
from both tissue sources. Future studies are necessary to deter-
mine the impact of cryopreservation on cell potential for thera-
py and de novo tissue generation.
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Introduction
Tissue engineering with adult multipotent stromal cells
(MSCs) harvested from adipose tissue, adipose derived
multipotent stromal cells (ASCs), is rapidly emerging as a
therapeutic reality in human and veterinary medicine [1, 2].
Higher MSC tissue density and comparable cell plasticity to
bonemarrow derivedmultipotent stromal cells are some of the
characteristics that establish adipose tissue as a viable MSC
source [3]. Existing knowledge supports potential differences
in ASC behavior among adipose depots in numerous species
[4, 5]. One rationale for observed differences is varying pro-
portions of brown and white adipose tissue among harvest
sites [6]. Intra-articular and visceral adipose tissue are pre-
dominantly white while subcutaneous adipose tissues are
mostly brown [7]. Distinctions between cells isolated from
brown versus white adipose tissue like lower plasticity of
brown adipose tissue cells, have been attributed to epigenetic
factors and functional differences, endocrine versus thermo-
genic of white and brown, respectively [8, 9]. Distinct features
of cells isolated from brown and white adipose tissues con-
tribute to efforts to optimize isolation procedures and culture
conditions for cells from each [10].
Canine infrapatellar adipose tissue ASCs reportedly have
similar in vitro properties as bone marrow derived multipotent
stromal cells and higher expansion capacity and plasticity than
undifferentiated cells from joint capsular and cranial cruciate
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ligament synovium [11]. This makes them appealing for intra-
articular tissue regeneration. Subcutaneous adipose tissue har-
vest is less invasive and more abundant than intra-articular
[12, 13]. Hence, use of subcutaneous adipose tissue ASCs
may reduce morbidity and augment tissue resources for gen-
eration of intra-articular structures.
A recent study highlighted differences between ASCs
from intra-articular and subcutaneous adipose tissues in
and around the human knee [12]. Published reports of
canine subcutaneous and infrapatellar ASCs suggest simi-
larities between cells from the two harvest sites [10, 14],
but a side by side in vitro characterization is necessary to
anticipate the ability of each cell type to support complex
tissue generation. This study was designed to determine
in vitro expansion capabilities and plasticity of paired ca-
nine ASCs harvested from subcutaneous (SUB) and
infrapatellar (IFP) adipose tissues before and after cryo-
preservation to test the hypothesis that IFP ASCs have
the highest in vitro expansion rates, plasticity and MSC




All animal procedures were approved by the Institutional An-
imal Care and Use Committee.
Study Design
Subcutaneous and IFP adipose tissues were collected from six
adult, mixed-breed dogs (3.5±0.8 years of age, mean±stan-
dard error of the mean (SEM)). Adipocyte and ASC ultra-
structure were evaluated with transmission electron microsco-
py (TEM). Cell doublings (CDs) and doubling time (DT) were
determined for fresh and cryopreserved ASC passages (fresh,
P; cryopreserved, tP) 0–3 from both tissues of each dog. For
P0, 1, 3 and tP1 and 3, CD29+, CD34+, CD44+, and CD90+
cell percentages were quantified. Fibroblastic (CFU-F), oste-
oblastic (CFU-Ob), and adipocytic (CFU-Ad) colony-forming
unit frequency percentages and lineage-specific target gene
mRNA expression levels were determined (peroxisome
proliferator-activated receptor γ (PPAR-γ) and leptin - adipo-
genesis; osteoprotegerin (OPG) and collagen type 1α1
(Col1α1) - osteogenesis) after culture in lineage-specific in-
duction or stromal media. Similarly, P3 and tP3 chondrogenic
pellet alcian blue (proteoglycan) staining, CD29, CD34,
CD44 and CD90 protein expression and target protein expres-
sion (PPAR-γ - adipogenesis; osteopontin (OPN) - osteogen-
esis; sex determining region Y-box 2 (SOX2) – progenitor)
were also quantified following standard induction procedures.
A seeding density of 5×103 cells/cm2 and humidified culture
conditions (37 °C, 5 % CO2) were used for all cell culture
experiments. Materials were from Sigma-Aldrich, St. Louis,
MO unless otherwise noted.
Cell Isolation
Cells from SUB and IFP adipose tissues were isolated accord-
ing to published procedures with minor modifications [11].
Briefly, tissue was rinsed with phosphate buffered saline
(PBS, Hyclone, Logan, UT) and minced, followed by diges-
tion in an equal volume of Dulbecco’s modified Eagle’s me-
dium: F-12 (DMEM/F-12, Hyclone, Logan, UT), 0.1 % col-
lagenase type I (Worthington Biochemical Corporation, Lake-
wood, NJ) and 1 % bovine serum albumin (BSA) for 90 min
with agitation. The tissue suspension was then filtered
(100 μm, BD Falcon, Bedford, MA). Subsequently, the digest
was centrifuged (260×g, 5 min), and the pellet was suspended
in stromal medium (DMEM/F-12 medium, 10 % (v/v) fetal
bovine serum (FBS, Hyclone), 1 % (v/v) antibiotic/
antimycotic solution). An equal volume of red cell lysis buffer
(0.16 mol/L NH4Cl, 0.01 mol/L KHCO3, 0.01 % ethylenedi-
aminetetraacetic acid (EDTA)) was added, and the mixture
was maintained at room temperature for 30 min. The solution
was centrifuged, and the resulting stromal vascular fraction
(SVF) pellet resuspended in stromal medium followed by cul-
ture in T75 flasks (CellStar, Greiner, NC). Medium was
refreshed after 24 h to remove unattached cells, and then every
3 days [11]. Subsequent passages were performed at 70–80 %
cell confluence. For purposes of this study, the primary cell
isolate was the SVF and the first cell passage of primary cells
was P0. Aliquots of each SVF were suspended in freezing
medium (10 % DMEM/F-12, 10 % dimethyl sulfoxide
(DMSO, Fisher Scientific, Fair Lawn, NJ), 80 % FBS) during
the first cell passage and cryopreserved in liquid nitrogen for a
minimum of 30 days. Cells were revitalized and seeded in T75
flasks as tP0 after the cryopreservation period.
Adipocyte and ASC Ultrastructure (Adipocytes, P1,
tP1) - Transmission Electron Microscopy
Harvested SUB and IFP adipose tissues, P1 and tP1 ASCs
were rinsed with PBS and then fixed in 2 % paraformaldehyde
and 1.25 % glutaraldehyde in 0.1 M sodium cacodylate
(CAC) buffer (pH 7.4). Samples were rinsed in 0.1 M CAC
buffer with 5 % sucrose and incubated with 1 % osmium
tetroxide in 0.1 M CAC buffer. The tissues were dehydrated
in a series of ethanol-distilled water solutions and embedded
in Epon (Plano, Marburg, FRG). Ultrathin sections were eval-
uated with a transmission electron microscope (JEM-1011,
JEOL, Japan).
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Cell Expansion (P0-3, tP1- 3)
Cells were cultured in 12-well plates (Thermal Fischer Scien-
tific, Denmark) to calculate CD and DTafter 2, 4 and 6 days of
culture using standard formulae (CD=ln(Nf/Ni)/ln(2) and
DT=CT/CD; Ni: initial cell number; Nf: final cell number;
CT: culture time) [15]. Cell counts were performed with a
hemocytometer. Day 2 and 4 cell numbers were used as the
Ni for days 4 and 6, respectively.
Multipotentiality (P0, 1, 3, tP1, 3) - Limiting Dilution
Assays and Pellet Chondrogenesis
Limiting dilution assays were used to determine fibroblastic
(CFU-F), adipocytic (CFU-Ad), and osteoblastic (CFU-Ob)
colony-forming unit frequencies [3]. A total of 5000, 2500,
1250, 625, 312 or 156 cells were seeded in each well of one
row in a 96-well plate for eight replicates of each cell number/
well. Fibroblastic (CFU-F) colonies were fixed with 2 % for-
malin (Anapath, Mckinney, TX) and stained with 0.1 % tolu-
idine blue after 7 days of culture in stromal medium. For CFU-
Ob, cells were cultured in stromal medium for 7 days followed
by culture in osteogenic medium (DMEM/F-12, 10 % FBS,
10 mmol/L β-glycerophosphate, 10 nmol/L dexamethasone,
50 μg/ml sodium 2-phosphate ascorbate) for 21 additional
days. Cells were fixed in ice cold 70 % ethanol and then
alkaline phosphatase (ALP) was stained with 5-bromo-
4chloro-3indolyl phosphate/nitro blue tetrazolium
(BCIP/NBT, 0.15 mg/ml BCIP, 0.30 mg/ml NBT). To deter-
mine CFU-Ad, cells were cultured in stromal medium for
7 days followed by culture in adipogenic medium
(DMEM/F12, 3 % FBS, 1 % antibiotic/antimycotic solution,
33 μmol/L biotin, 17 μmol/L pantothenate, 1 μmol/L dexa-
methasone, 100 μmol/L indomethacin, 1 μmol/L insulin,
0.5 mmol/L isobutylmethylxanthine (IBMX), 5 μmol/L
rosiglitazone (TZD, AK Scientific, Union City, CA)) for 21
additional days. Cells were fixed in 4 % formalin and stained
with 0.3 % oil red O. Wells with 10 or more toluidine blue-
stained, oil red O-stained, or BCIP/NBT-stained colonies were
considered positive for fibroblastic, adipocytic or osteoblastic
colonies, respectively. The ratio of negative to total wells per
row was used to estimate the CFU frequencies according to
Poisson’s ratio (F=e-x; F: ratio of negative to total wells; e:
natural logarithm constant 2.71; x: CFU/well) [3, 11, 15].
CFU frequency was expressed as a percentage (1/CFU fre-
quency×100).
For chondrogenesis, 2.5×105 cells were centrifuged
(200×g, 5 min) to form a pellet after 7 days of culture in
stromal medium. Pellets were cultured in stromal or
chondrogenic medium (DMEM/F-12, 3 % FBS, 1 %
antibiotic/antimycotic solution, 50 μg/ml ascorbate phos-
phate, 100 nmol/L dexamethasone, 40 μg/mL proline,
2 mmol/L sodium pyruvate (Invitrogen, Carlsbad, CA), 1 %
insulin-transferrin-selenium (ITS, Invitrogen), 10 ng/mL re-
combinant human transforming growth factor-β3 (rTGF-β3,
R&D systems, Minneapolis, MN)) for 21 days. They were
then fixed with 10 % neutral buffered formalin, embedded in
paraffin, sectioned (5 μm) and stained with 1 % alcian blue
(Acros Organics, Belgium) and 3 % nuclear fast red.
Immunophenotype - Flow Cytometry (P0, 1, 3, tP1, 3)
Cell aliquots (105 cells) were suspended in 200 μl PBS con-
taining 0.1 μl (200 μg/ml) of labeled or unlabeled antibody
(CD34-PE, CD44-FITC, CD90-PE, CD29) specific for canine
antigens or validated for canine cross reactivity for 30 min at
room temperature (Table 1). Cells were then washed with PBS
and fixed with 4 % neutral buffered formalin. For CD29, cells
were incubated with labeled anti-immunoglobulin (IgG-
FITC) for 30 min at room temperature, washed with PBS
and then fixed with 4 % neutral buffer formalin. For the
autoflourescence control, cells were not incubated with anti-
bodies. Cell fluorescence was quantified by flow cytometry
using a FACSCalibur flow cytometer and Cell Quest Pro soft-
ware (BD Biosciences, San Jose, CA).
Gene Expression – RT-PCR (P0, 1, 3, tP1, 3)
Total RNA was isolated from cells (RNeasy Plus Mini Kit,
Qiagen) and the concentration determined spectrophotometri-
cally (NanoDrop ND-1000; NanoDrop Technologies,
Montchanin, DE, USA). A QuantiTect Reverse Transcription
Kit (Qiagen, GmbH, Germany) was used to generate cDNA.
Target gene levels, glyceraldehyde 3-phosphate dehydroge-
nase (GAPDH), PPAR-γ, leptin, Col1α1 and OPG (Table 2)
were quantified with real-time RT-PCR using SYBR Green
(Qiagen) technology and an MJ Research Chromo 4 Detector
(Bio-Rad Laboratories, Hercules, CA). The 2 –ΔΔCt values
were determined relative to the reference gene GAPDH and
target gene expression in cells cultured in stromal medium.
Protein Expression – Immunocytochemistry,Western Blot
(P3, tP3)
Immunocytochemistry Cells were cultured in stromal medi-
um in 4-well chamber slides for 3 days and then fixed with
10 % neutral buffered formalin for 24 h. Antigen retrieval was
performed with SDS/TBS antigen retrieval buffer (1 % SDS,
100 mMTris, 138 mMNaCl, 27 mMKCl, pH=7.4) for 5 min
at room temperature. Cell preparations were blocked with goat
serum (1:10 in TBS) overnight at 4 °C and then incubated
with antibodies against CD34-PE (1:200), CD44-FITC
(1:500) or CD90-PE (1:500) (Table 1) for 2 h at room temper-
ature. Cells were washed with TBS buffer and nuclei were
stained with DAPI (1 μg/ml). For CD29 labeling, cells were
incubated with antibodies against CD29 (1:500) for 2 h at
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37 °C followed by IgG-FITC (1:800) and DAPI nuclear stain.
Photomicrographs were obtained for all labeled cells (Leica
DM 4500b).
Western Blot Total protein was extracted from cells cultured
in stromal and induction medium using RIPA buffer (150 mM
NaCl, 1.0 % Triton X-100 (Thermo Scientific, Rockford, IL),
0.5 % sodium deoxycholate, 0.1 % SDS, 50 mM Tris (pH=
8.0), protease inhibitor (Thermo Scientific)). Protein concen-
trations were determined with the Bicinchoninic Acid (BCA)
Protein Assay Kit (Thermo Scientific). Protein aliquots
(20 μg) were denatured for 10 min at 95 °C in an equal vol-
ume of 1× SDS loading buffer. Proteins were separated on a
12 % SDS-PAGE gel and transferred (300 mA, 90 min) to
nitrocellulose membranes (Bio-Rad Laboratories, Hercules,
CA). Membranes were blocked (4 % BSA, 0.05 % sodium
azide) for 1 h at room temperature and then incubated with
primary antibodies directed against OPN (1:300), PPAR-γ
(1:500) or SOX2 (1:500) at 4 °C overnight (Table 1). Tris
buffer saline with Tween-20 (TBST, 0.1 % Tween-20,
0.24% Tris, 0.8 %NaCl) washes were followed by incubation
with horseradish-peroxidase-conjugated (HRP) IgG (1:3000)
at room temperature for 2 h. Labeled bands were imaged by
exposure to light sensitive film (GE Healthcare, Chalfont St.
Giles, Buckinghamshire, UK) following color development
with Amersham ECL prime western blotting detection re-
agents (GE Healthcare). The relative density of target protein
bands were determined normalized to β-actin standards
(ImageJ v1.49p, National Institutes of Health, Bethesda, MD).
For evaluation of surface marker protein expression, total
protein was extracted with NP-40 buffer (150 mM sodium
chloride, 1.0 % Triton X-100, 50 mM Tris, pH=8.0) from
fresh and cryopreserved P3 cells cultured in stromal media.
Protein concentration determination and western blot proce-
dures were identical to above with the exception of incubation
with primary antibodies directed against CD29 (1:200) and
CD44 (1:2000) at room temperature for 1 h (Table 1) followed
by IgG-HRP (1:2000).
Statistical Analysis
Statistical analyses were performed with commercially avail-
able software (SAS 9.2, Institute, Cary, NC). Analysis of var-
iance (ANOVA) models were used to evaluate cell surface
marker percentages, CD, DT, CFU frequency percentages
and gene expression among tissue sources within passages
and among passages within tissue sources. Tukey’s post hoc
tests were applied for multiple group comparisons (p<0.05).
Table 1 Antibodies for Flow Cytometry and Immunocytochemistry
Antibody Label Marker expression Manufacturer Cat no. Species Target
species
Diluent
CD29 N/A β1 integrin BD Biosciences 610468 Mouse Human PBS
CD34 PE Hematopoietic progenitor
(HSC)
BD Biosciences 559369 Mouse Dog PBS
CD44 FITC Hyaluronic acid receptor eBiosciences 115440 Mouse Dog PBS
CD90 PE Thy-1, fibroblasts, MSC, HSC eBiosciences 125900 Mouse Dog PBS
Goat anti-mouse IgG FITC Secondary antibody Sigma-Aldrich F9006 Goat Mouse PBS
β-actin N/A Cytoskeletal protein Thermo Scientific RB-9421-P0 Rabbit Dog TBS
Sox-2 N/A Transcription factor LifeSpan BioSciences LS-B4562 Rabbit Dog 5 % Skim milk/PBS
PPAR-γ N/A NHR/NR1 Thyroid homone-like LifeSpan BioSciences LS-B651 Rabbit Dog 5 % BSA/TBS
OPN N/A Secreted Phosphoprotein 1 LifeSpan BioSciences LS-B425 Rabbit Dog 5 % BSA/TBS
CD29 N/A β1 integrin BD Biosciences 610468 Mouse Human TBS
CD44 N/A Hyaluronic acid receptor Monoclonal Antibody Center DG-BOV2037 Mouse Dog TBS
Goat anti-rabbit IgG HRP Secondary antibody Santa Cruz Biotechnology sc-2004 Goat Rabbit TBS
Goat anti-mouse IgG HRP Secondary antibody Santa Cruz Biotechnology sc-2005 Goat Mouse TBS
Table 2 Primer sequences
Lineage Primer Forward primer Reverse primer Accession no.
Housekeeping GAPDH TGGCAAAGTGGATATTGTCG AGATGGACTTCCCGTTGATG XM_003435649.2
Adipogenic PPAR-γ TTCTCCAGCATTTCCACTCC AGGCTCCACTTTGATTGCAC XM_005632014.1
Leptin TGTGTTGAAGCTGTGCCAAT CCCTCTGTTTGGAGGAGACA XM_005628342.1
Osteogenic Col1α1 GGTGGTGGCTATGACTTTGG CAGTTCTTGGCTGGGATGTT XM_005628344.1
OPG TGTCTATACTGCAGGCCGGTG TCAGGCAGAACTCAAGCTCCA XM_003639448.2
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Normality and homogeneity of variance were assessed with
Shapiro-Wilk tests and residual plots.
Results
Adipocyte and ASC Ultrastructure (Adipocytes, P1, tP1) -
Transmission Electron Microscopy
Adipocytes and ASCs had different morphologies from each
other and between tissue sources. There were large, unilocular
lipid vacuoles that peripherally displaced cytoplasm and or-
ganelles in adipocytes from both tissue sources. However,
SUB adipocytes had numerous mitochondria concentrated
near the cell membrane compared to mitochondria distributed
throughout the cytoplasm in IFP adipocytes. Further, IFP ad-
ipocytes had abundant small lipid vacuoles (in addition to the
central vacuole) among mitochondria whereas SUB had fewer
(Fig. 1). Cultured ASCs were smaller than adipocytes, and
they did not have central, large lipid vacuoles. Fresh IFP and
SUB ASCs had mitochondria clustered around the nucleus
and small, cytoplasmic lipid vacuoles, though IFP ASCs
tended to have more vacuoles and fewer mitochondria. After
cryopreservation, IFP ASCs had many small lipid vacuoles
and few mitochondria in the cytoplasm compared to few lipid
vacuoles in the cytoplasm and mitochondria clustered around
the nucleus in SUB ASCs (Fig. 1). The perinuclear mitochon-
dria apparent in the fresh IFPASCs were not detectable in the
same cells after cryopreservation. Additionally, the relative
number of mitochondria in cryopreserved SUB ASCs ap-
peared to be lower than in fresh ASCs based on subjective
assessment.
Cell Expansion (P0-3, tP1-3)
The CDs of fresh and revitalized IFP and SUB ASCs de-
creased with passage, while the corresponding DTs increased
(Fig. 2). Significant differences were less incremental in fresh
versus cryopreserved cells with P0 and 1 tending to expand
more quickly than P2 and 3. The CDs were significantly lower
for P0 SUB ASCs versus IFPASCs (Fig. 2a). The CDs were
significantly lower (Fig. 2e) and the DT significantly higher
(Fig. 2f) for cryopreserved P3 versus fresh ASCs from the
same tissue source.
Multipotentiality (P0, 1, 3, tP1, 3) – Limiting Dilution
Assays and Pellet Chondrogenesis
Based in histochemical staining, fresh and revitalized IFP
and SUB ASCs showed robust adipogenesis and osteogen-
esis for all passages evaluated. The CFU frequency per-
centage indicates the percentage of cells capable of
forming a colony of fibroblastic (CFU-F), osteoblastic
(CFU-Ob) or adipogenic (CFU-Ad) lineage. Before and
after cryopreservation, SUB and IFP ASCs showed similar
CFU frequency percentages, and, though values tended
decrease after cryopreservation, they were not significantly
different among fresh and cryopreserved cells from the
same tissues within passages (Fig. 3). In fresh cells, the
frequencies decreased with passage and were significantly
lower in P3 versus P0. For CFU-F, P0 and 1 were signif-
icantly higher than P3, and for CFU-Ob, P0 was signifi-
cantly higher than P1 which was significantly higher than
P3. The only difference in behavior between cell sources
was that P1 SUB ASC CFU-Ad was significantly lower
than P0 while IFP ASC CFU-Ad was significantly higher
in P0 and 1 than P3 in fresh cells. Fresh SUB and IFP
ASCs displayed characteristic chondrogenic differentiation
including glycosaminoglycan (GAG) deposition and tissue
organization, both of which were absent in the control
group (Fig. 4).
Immunophenotype -Flow Cytometry (P0, 1, 3, tP1, 3)
The majority of fresh cells from both adipose tissue depots
were CD29+, CD44+, CD90+ and CD34- for all passages
evaluated (Fig. 5). The percentage of CD29+ ASCs was sig-
nificantly higher in P0 compared to 1 and 3 for fresh SUB and
Fig. 1 Transmission electron microscopy (TEM) image of adipocytes and
adipose derived multipotent stromal cells (ASCs) from canine
subcutaneous (SUB) and infrapatellar (IFP) adipose tissues. Legend: 1 –
nucleus, 2 – euchromatin, 3 –mitochondria, 4 – Golgi apparatus, 5 – lipid
droplet, 6 – lysosome. Scale bar=2 μm
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IFP ASCs (Fig. 5a). There were significantly higher percent-
ages of CD29+ and CD44+ ASCs in revitalized P1 versus P3
for both tissue sources (Fig. 5a, c). Fresh P1 SUB and P3 SUB
and IFPASCs had significantly higher percentages of CD29+
cells than the same passages after cryopreservation (Fig. 5a).
There were significantly higher percentages in of CD44+ P1
ASCs after cryopreservation compared to fresh cells within
tissue source (Fig. 5c). However, cryopreserved P3 ASCs
Fig. 2 Cell doublings (CD) and
doubling time (DT) (mean±
SEM) for fresh (a, b), revitalized
(c, d) and both fresh and
revitalized (-R) canine ASCs (e, f)
from SUB and IFP adipose
tissues. Columns with asterisks
within passages are significantly
different between cell tissue
source (a), columns with distinct
superscripts within cell tissue
source (a–d), and columns with
distinct superscripts within
passage (e, f) are significantly
different (P<.05)
Fig. 3 Colony forming unit (CFU) frequencies (mean±SEM) for fresh
(a, b, c) and revitalized (d, e, f) canine ASCs from subcutaneous (SUB) or
infrapatellar (IFP) adipose tissue after culture in stromal (CFU-F),
osteogenic (CFU-Ob), or adipogenic (CFU-Ad) medium. Columns with
different superscripts within cell source are significantly different among
passages (P<.05)
262 Stem Cell Rev and Rep (2016) 12:257–268
had significantly lower percentages of CD44+ than fresh. The
percentage CD90+ cells was significantly lower in fresh P3
SUB ASCs compared to cryopreserved P3 SUB ASCs
(Fig. 5d).
Gene Expression - RT-PCR (P0, 1, 3 tP1, tP3)
The stability of the reference gene, GAPDH, was confirmed
based on a mean CT value of 18.18±0.22 for all samples.
With increasing passage, adipocytic and osteoblastic target
gene expression decreased significantly in both fresh and
cryopreserved cells (Fig. 6). Both P1 and tP1 SUB and IFP
ASCs had significantly higher levels of PPAR-γ and leptin
after adipogenic induction (Fig. 6a, b) as well as OPG and
Col 1α1 after osteogenic induction compared to P3 and tP3
(Fig. 6c, d). Additionally, PPAR-γ expression was significant-
ly in lower in P3 ASCs following induction after cryopreser-
vation in cells from both tissue sources.
Protein Expression – Immunocytochemistry,Western Blot
(P3, tP3)
Immunocytochemistry Cell surface marker expression
(CD29+, CD44+, CD90+, CD34−) was confirmed with im-
munocytochemistry in all ASCs before and after cryopreser-
vation (Fig. 7).
Western Blot The SOX2 protein expression was lower in
cryopreserved (-R) ASCs from both tissues cultured in stromal
medium (Fig. 8a, d). Additionally PPAR-γ and OPN protein
Fig. 4 Light photomicrographs of fresh P3 canine ASCs from SUB (a, b) and IFP (c) after pellet culture in stromal (a) or chondrogenic (b, c) medium.
Alcian blue staining of proteoglycans with nuclear fast red counter stain. 63× magnification. Scale bar=20 μm
Fig. 5 Percentages (mean±SEM) of CD29+ (a), CD34- (b), CD44+ (c)
and CD90+ (d) fresh and revitalized (−R) ASCs from canine SUB and
IFP adipose. Columns connected by lines with asterisks are significantly
different within passage and columnswith distinct superscripts within cell
tissue source and treatment (fresh or cryopreserved) are significantly
different among passages (P<.05)
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expression increased while SOX2 expression decreased in
fresh and revitalized P3 ASCs cultured in adipogenic and
osteogenic induction medium, respectively (Fig. 8b–f). The
singular exception was revitalized P3 SUB ASCs in which
SOX2 expression was essentially the same in cells cultured
in adipogenic and stromal medium. Cryopreserved P3 SUB
and IFPASCs had lower CD29 and CD44 protein expression
compared to fresh P3 ASCs (Fig. 9).
Discussion
Paired comparisons of fresh and revitalized ASCs from canine
SUB and IFP adipose tissue in this study showed comparable
in vitro expansion and multipotentiality up to passage 3. Fresh
and cryopreserved canine ASC expansion metrics, CD and
DT, and CFU frequency percentages had similar values and
cell passage changes to previous reports using the same [3,
11]. However, detectable effects of cryopreservation on ultra-
structure, immunophenotype, and both surface marker and
transcription factor expression indicates that cryopreserved
canine ASCs may not be directly interchangeable with fresh.
In spite of the potential impact of cryopreservation on ASC
potential, study results suggest that ASCs from either tissue
source are promising candidates for future studies to optimize
cell isolation, cryopreservation, tissue regeneration strategies
and therapeutic applications.
The ultrastructures observed in this study were similar to
those reported for other species [16, 17] including abundant
cytoplasmic mitochondria [16] and many small lipid vacuoles
[17] in brown and white adipocytes, respectively. The charac-
teristics are consistent with lipid energy storage [8, 18] and the
role of the inner mitochondrial membrane in thermogenesis
[19, 20].Mature adipocytes are post-mitotic, so cell precursors
rapidly differentiate in response to energy demands [21, 22].
As such, immature cells at many stages of differentiation as-
sume characteristics of the mature cells as observed in the
ASCs in study. This is also consistent with the current knowl-
edge that white and brown adipocytes are derived from dis-
tinct precursor populations [23–25].
Fewer mitochondria surrounding the nucleus after cryo-
preservation may indicate greater maturity in revitalized cells.
Mitochondrial localization is a characteristic of mammalian
cleavage-stage embryos that is strongly indicative of stem cell
competence, and alterations may be associated with dimin-
ished pluripotency [26, 27]. The percentage of cells with
perinuclear mitochondria decreased while that of cells with
lipid droplets increased with cell passage in an adult primate
adipose derived stem cell line [26]. Reduced perinuclear mi-
tochondria were associated with lower oxygen consumption
and higher adenosine triphosphate, both consistent with lower
Fig. 6 Fold change (mean±SEM) of adipogenic (a, b) and osteogenic (c,
d) lineage target genes in fresh and revitalized (t) canine ASCs from
subcutaneous (SUB) and infrapatellar (IFP) adipose tissue cultured in
induction medium. Values are relative to the reference gene GAPDH
and to cells cultured in stromal medium. PPAR-γ = Peroxisome
proliferator-activated receptor γ, OPG = Osteoprotegerin, Col 1α1 =
Collagen Iα1. Columns with different superscripts within cell tissue
source are significantly different (P<.05)
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metabolic energy requirements of differentiated cells. The de-
crease in mitochondria after cryopreservation in this study was
a subjective assessment, so the magnitude of the change could
not be quantified or directly compared between ASC tissue
Fig. 7 Fluorescent photomicrographs of SUB and IFP fresh and revitalized canine P3 ASCs from subcutaneous (SUB) and infrapatellar (IFP) adipose
tissue labeled with cell surface markers indicated. 40× magnification. Scale bar=50 μm
Fig. 8 Western blot image of proteins from fresh and revitalized (−R)
canine P3 ASCs from subcutaneous (SUB) and infrapatellar (IFP)
adipose tissue after culture in stromal (a), adipogenic (b) or osteogenic
(c) medium with corresponding graphs indicating relative density (d–f).
PPAR-γ = Peroxisome proliferator-activated receptor-γ, SOX2 = Sex
determining region Y box-2, OPN = Osteopontin
Stem Cell Rev and Rep (2016) 12:257–268 265
sources. A consistent finding was that the distribution of mi-
tochondria was similar within cells from specific tissue
sources and the relative prevalence was reduced following
cryopreservation.
Current knowledge suggests that loss of mitochondria may
be a result of organelle disruption and/or cell selection by the
cryopreservation process [28, 29]. The potential for cell selec-
tion is further supported by increased numbers of lipid vacu-
oles post-cryopreservation. The cryoprotectant used in this
study, DMSO, is a standard component of cryopreservation
media for cell protein and membrane stabilization [29, 30] and
to prevent intracellular ice formation [29]. At non-toxic
DMSO levels, and despite a slow freezing process, intracellu-
lar ice formation is not fully prevented [31–33]. Fewer mito-
chondria and more abundant lipid vacuoles are associated
with greater cell maturity as indicated above [26, 27]. Based
on the these findings, it is possible that the higher lipid content
of more mature cells within the heterogeneous cell isolate
confers a higher transition temperature during freezing [34].
Together with the DMSO, the higher lipid content may protect
against ice formation and thereby select for greater cell matu-
rity. Further studies are required for confirmation of this
finding.
Additional distinctions between fresh and cryopreserved
ASCs were decreases in cell percentages expressing CD29
and CD44, multipotent stromal cell phenotypic markers that
are stably expressed in ASCs [2]. Exceptions included variable
CD90 expression and an initial increase in the number of
CD44+ cells in P1 cryopreserved cells. Previous studies iden-
tified increased CD90 expression in revitalized cells versus
fresh MSCs from human umbilical cord and rat adipose and
bone marrow tissues [35, 36]. It is generally accepted that due
to the presence of CD90 in the endothelial population, changes
in expression are best interpreted in combination with the ex-
pression of other surface markers [2]. The initial increase in
CD44 expression in revitalized cells that was not paralleled in
CD29 expression could be due to an increase in CD44 expres-
sion by cells that do not express CD29, potentially due to high
protein concentrations in FBS. The principle ligand of CD44 is
hyaluronic acid (HA) [37]. Murine cumulus cell-oocyte com-
plexes retain HA in the extracellular matrix and expand in the
presence of FBS [38]. In contrast, HA is released into the cul-
ture medium in the absence of FBS, the cells dissociate and
attach to culture ware as individual cells [38]. Hence, high
concentrations of FBS in the freezing medium may increase
local HA concentrations and stimulate upregulation of the re-
ceptor in cells in the passage immediately post revitalization.
In general, there were fewer cells expressing CD29 and
CD44 after cryopreservation within passages, with the excep-
tions discussed above, and passage effect tended to be more
profound in cryopreserved cells. Lower CD29 and CD44 ex-
pression was confirmed by western blot. Upregulation of ap-
optotic genes and increased apoptosis is associated with cryo-
protectants and the cryopreservation process itself [30, 39].
Additionally, DMSO concentrations of 10 % or higher reduce
the number of porcine ASC fibroblastic colony forming units
and increase cell apoptotic gene expression after cryopreser-
vation [30]. A previous study confirmed that the expression of
adhesion molecule CD62L [40] was lost while CD57, an ap-
optosis protein [41], increased after cryopreservation in CD4+
and CD8+ T cells [39]. Based on this established information,
decreases in CD44 and CD29 post cryopreservation suggests
a similar and important effect on canine SUB and IFP ASCs
that should be considered for cell therapy and tissue regener-
ation strategies.
Decreases in SOX2 protein expression and PPAR-γ gene
expression observed in this study further suggests that cryo-
preservation may impact ASC plasticity. Both are early tran-
scription factors, SOX2 is associated with the multipotent
ASC phenotype [42, 43] and PPAR-γ is a nuclear receptor
that controls energy metabolism and cell differentiation that
is highly expressed in ASCs [44, 45]. It further controls tran-
scription of genes for radical oxygen species detoxification
enzymes [46]. Recently, mitochondria were shown to be cen-
tral to oligodendrocyte differentiation and major targets of
PPAR-γ agonist protection against inflammatory cytokine
damage [44]. The fact that PPAR-γ protein expression was
not significantly lower in P3 ASCs after cryopreservation is
likely because gene and protein expression is not necessarily
parallel, and changes in gene expression typically precede
alterations in protein levels. Lower expression of both SOX2
and PPAR- γ in addition to the reduced presence of cellular
Fig. 9 Western blot image (a) and corresponding relative density graph (b) of fresh and revitalized (t) P3 ASCs following culture in stromal medium
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mitochondria may indicate greater cell vulnerability to inflam-
matory byproducts in addition to decreased differentiation
capacity.
As a whole, these in vitro study results indicate that there
are few differences between canine SUB and IFPASCs before
and after cryopreservation. The impact of cryopreservation on
the cells is strongly supported at the genetic, protein and ul-
trastructural levels and appears to be consistent with reduced
expansion capacity and plasticity associated with greater cell
maturity. Cryopreservation is vital to storage and transport of
progenitor cells [47–49]. It is especially important given the
growing recognition of the importance of cell phenotype for
specific therapeutic and tissue regeneration purposes [50–52].
Continued efforts to minimize the impact of cryopreservation
on ASC properties as well mechanisms to clearly delineate
and anticipate the effects will continue to improve cell-based
therapies and tissue regeneration.
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